Men Need To Be Aware of Possible Symptoms of
Prostate Problems
Enlargement of the prostate is called benign
prostate hypertrophy, or BPH. While this growth is
usually considered a nuisance, if a man experiences problems
with burning, or difficult urination at any time, the prudent
course of action is consulting a urologist.
Other symptoms may be:
- A feeling of having to push out urine
- A sensation that the bladder is not emptying
- Increased urinating, especially at night
- Intermittent starting and stopping of the urinary
stream
After a diagnosis of BPH, many men will just continue
to live with the symptoms and subsequent prostate
discomfort. It is not a life threatening
condition, and there are treatments. In some
cases surgery might be considered if the enlargement is
significant.
Ignoring BPH can be extremely dangerous
and lead to other disease such as kidney infections or damage
as the urine can back up into the kidneys because of the
blockage of an enlarged prostate. There can
also be an occurrence of bladder infections.
There is a huge difference between BPH and
prostate cancer. BPH is a normal part of
aging. Prostate cancer is a condition where
prostate cells grow exponentially and out of
control. These cells create tumors that may
spread to any part of the body.
Numerous health organizations report that 1 in 6 men
will experience prostate cancer. However, if the
condition is diagnosed early, approximately 99.3% of them will
survive. The key is early
detection.
Prostate Diagnostic Testing
Prostate cancer can occur in any man, but there are
certain “risk groups.” Younger African American
men appear to have twice the risk and fatalities of
Caucasians. Sadly, many are diagnosed
before they reach the age of 50.
Another risk group is men who have a family
history of prostate cancer, placing them in the same group who
may contract the disease before the age of
50.
The only method to determine whether you are at
risk for prostate cancer is diagnostic
testing. The earlier you are screened
the higher your chances of survival. Let’s
explore some of the diagnostic options.
Some Prostate Diagnostic Testing Options
Digital
Rectal Exam (DRE)
Testing begins with a digital rectal exam
(DRE). This examination has been the
benchmark for discovering cancer as well as
BPH. Your doctor can determine the condition
and size of the prostate by inserting a gloved finger into the
rectum.
Prostate Specific Antigen
(PSA)
In the mid-1980s’ the FDA approved the use of
monitoring blood levels for prostate specific antigen
(PSA). At that time, this was considered a
major breakthrough in the diagnosis and treatment for prostate
cancer.
Here's Why!
PSA readings specifically target prostate
cells. A healthy prostate gland produces a
constant level, usually 4 nanograms per milliliter which is
considered as a PSA reading of “4” or less.
Cancer cells produce growing amounts that
escalate. They correlate with the severity of
cancer. A PSA level greater than 4
will give the doctor some cause for
investigation. If the level reaches 10 he
will have cause to consider the presence of prostate
cancer. An amount over 50 may indicate that
the cancer has spread to other parts of the
body.
A PSA test usually measures the total amount that is
attached to blood proteins. However, later
research gained an FDA approval for a test called the Tandem R
test. This test also gives a measure of the
total PSA and reads another component called free
PSA. Free PSA floats unbound in blood.
Very Important!
Have these two tests to compare helps to rule out
prostate cancer in men whose PSA is just mildly elevated due to
other causes. A 1995 study in the Journal of the
American Medical Association shows that a free PSA test reduces
unnecessary prostate biopsies by 20% in certain patients whose
PSA is between 4 and 10.
As newer sophisticated methods are made available, it
is creating a controversy among the healthcare community
regarding “when” men should be screened, how often and whether
to screen men under 50 with no symptoms.
Some are saying that mass screening is expensive while
others point out reductions in mortality rates when early
screening diagnoses prostate cancer. The jury is
still somewhat “out” on that debate, but it never hurts to err
on the side of caution. It is your body,
after all!
It should be noted that both The American Urological
Association and The American Cancer Society recommend annual
PSA test for all men over 50 and for those at high risk over
40.
Take the case of Joe. A healthy, 36 year
old, robust father of two was required to take a routine
physical exam for his work-related
insurance. During this exam, his doctor
noted that his prostate was enlarged.
Unfortunately, the resulting tests proved that he did indeed
have prostate cancer. Further investigation
revealed that he was “at risk” based on family history.
Why take chances? Get yourself screened
so you have a benchmark, then having annual
screening. Remember, prostate cancer is slow
growing so the odds are in your favor when detected early.
Urine Test
A standard urine test can also help to diagnose
prostate problems by screening for blood or
infection. The chemical tests will also check for
liver, diabetes or kidney disease.
Hyperplasia INTRAVENOUSPYELOGRAM
(IVP)
This test is actually an X-ray. Dye is
injected into one of the major veins. While
the dye is circulating, pictures of vital organs are
taken. This test will record the progress of
the dye through the kidneys, bladder and ureter tubes (the
tubes that drain the kidneys). This test is
more or less optional since most men who have enlargement of
the prostate usually have no abnormalities of the ureter tubes
or kidneys in a normal urinalysis.
Bladder Ultrasound
This is a simple procedure that can be conducted right
in the doctors’ office. It is non-invasive and
determines if there is urine left in the bladder after
urination. If a large amount of urine
remains, it could be an indicator of enlarged prostate that is
not allowing the bladder to be completely emptied.
Prostate Ultrasound
This is a test to estimate the size of the prostate by
using state of the art software that helps guide the
physician. The prostate ultrasound is also
important if a biopsy is called for which we will discuss
later.
Uroflow
This is a simple test that entails the patient
urinating into a container and measuring how strong the stream
of urine is.
Radionuclide Bone
Scan
A test that can be used if staging (see below)
indicates that cancer has spread into the lymph
nodes. If the tumor has spread to the lymph nodes,
bone commonly follows. However, if PSA
levels are under 10ng and there is no indication of bone pain,
physicians find that the presence is so unlikely that this
procedure is skipped.
Cystoscopy
This test allows the physician to visually examine the
bladder and prostate. This is done by inserting an
instrument through the urethra.
Computed Axial Tomography (CAT)
This is another test that could identify cancer in
remote areas of the body. Without probable cause,
like the Radionuclide Bone Scan above, it is probably
unnecessary just as the
Magnetic Resonance Imaging (MRI)
This test may be unnecessary, especially if the
prostate cancer is localized.
Pelvic Lymph Node Dissection
Considered to be the “final check” to determine if
cancer has spread, this procedure can be completed through
normal open surgery but more often is conducted using a fiber
optic probe that is inserted through a small incision in your
abdomen.
All of these diagnostic tests are tools to determine
whether there is a possibility of cancer present in the
prostate and if so, just how invasive it may be.
However, there is only one way certain method to
determine the presence of cancer cells and that is by examining
the tissue itself.
Based on the findings of the tests we have discussed,
if a physician determines that there may be cancer cells he
will recommend a biopsy.
A biopsy is conducted by a urologist and the procedure
is normally done right in his office. Here is
where the ultrasound we discussed previously comes into
play. Using a transrectal ultrasound (TRUS),
the doctor will image the prostate by using sound waves by
inserting an instrument into your rectum.
This allows the doctor to “image” the
prostate. He will use biopsy needles that
are hollow into any area of the prostate that looks or feels
suspicious. Small bits of tissue are
extracted through the needle. You may feel a
stinging sensation.
Depending on the reasons for the
biopsy, the doctor may take samples randomly. For
instance, if the biopsy is conducted due to elevated PSA
instead of a suspected abnormality in the prostate gland, as
many as a half dozen or more samples may be
taken. This is considered a “pattern biopsy”
and is done to help determine the size and invasiveness of any
cancer. Even though you may have multiple
samples, a biopsy can still miss some cancers.
Once the biopsy is complete, the tissue samples are
taken to a pathologist to determine the presence of cancer
cells.
Normal prostate cells are usually uniform in size and
are neatly patterned when viewed under a
microscope. They appear similar to one another in
an orderly manner.
Abnormal cells change their appearance and are not
well defined. They will usually appear as
misshapen and irregular.
As they deteriorate, a tumor can appear.
Tumors can be benign (non-cancerous) or malignant
(cancerous).
If the pathologist determines the presence of prostate
cancer, he will “grade” each of the tissue
samples. This will determine how advanced beyond
normal the cancerous tissue has developed.
This grading system gives the physician a good idea as to how
the tumor is behaving. Tumors with a low
grade are most likely to be slow-growing.
Tumors with a high grade are more apt to spread aggressively or
may have already spread outside of the prostate.
If the latter is true, it is said to be
“metastasized.”
The actual grading system most widely used by
pathologists is the Gleason Grading System,
developed in 1977 by Pathologist Donald Gleason.
You will find the Gleason
Scores in numerous places on and off the internet as it is
a standard method.
That concludes the article for now, however, Health
Proactive will be publishing additional information on the
Gleason Grading System.
DISCLAIMER: This information is not presented by
a medical practitioner and is for educational and
informational purposes only. The
content is not intended to be a substitute for
professional medical advice, diagnosis, or
treatment. Always seek the advice of
your physician or other qualified health provider with
any questions you may have regarding a medical
condition. Never disregard
professional medical advice or delay in seeking it
because of something you have read.
|